Novel combination of AR inhibitor and CDK4/6 inhibitor, MEK inhibitor in non-HR positive breast cancers. (April 2018) - Lim, B.; Lee, L.; Pearson, T.; Liu, H.; Hwang, M.; Choi, K.; Tripathy, D.; Ueno, N.T.